Sustained Function and Enhanced Replicative Capacity of Anti-Tumor CD4+Effectors by Enforced Co-Stimulation

被引:0
|
作者
Chang, Lufen [1 ]
Jensen, Michael [1 ]
机构
[1] City Hope Natl Med Ctr, Div Canc Immunotherapeut & Tumor Immunol, Beckman Res Inst City Hope, Duarte, CA 91010 USA
关键词
D O I
10.1016/j.ymthe.2006.08.707
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
632
引用
收藏
页码:S243 / S244
页数:2
相关论文
共 50 条
  • [1] Sustained function and enhanced replicative capacity of anti-tumor CD4+effectors by enforced costimulatory signallings
    Chang, Lufen
    Aguillar, Brenda
    Hamlett, Aracceli
    Chang, Wen-Chung
    Jensen, Michael
    JOURNAL OF IMMUNOTHERAPY, 2006, 29 (06) : 628 - 628
  • [2] Transgene-enforced co-stimulation of CD4+ T cells leads to enhanced and sustained anti-tumor effector functioning
    Chang, L.
    Chang, W. C.
    McNamara, G.
    Aguilar, B.
    Ostberg, J. R.
    Jensen, M. C.
    CYTOTHERAPY, 2007, 9 (08) : 771 - 784
  • [3] T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
    Canel, Marta
    Taggart, David
    Sims, Andrew H.
    Lonergan, David W.
    Waizenegger, Irene C.
    Serrels, Alan
    ELIFE, 2020, 9
  • [4] In vitro co-stimulation of anti-tumor activity by soluble B7 molecules
    He, Wei
    Hu, Zhong-Bo
    Liu, Fang
    Feng, Xian-Qi
    Zou, Ping
    ACTA BIOCHIMICA POLONICA, 2006, 53 (04) : 807 - 813
  • [5] Coupling CD28 co-stimulation to IgTCR-mediated anti-tumor immunity: dynamics of tumor and T cell interactions
    Ripley, R
    Ma, J
    Safar, M
    Junghans, RP
    Beecham, EJ
    CANCER GENE THERAPY, 2001, 8 : S28 - S28
  • [6] TCR/CD3 activation and co-stimulation combined in one T cell retargeting system improve anti-tumor immunity
    Cartellieri, Marc
    Arndt, Claudia
    Feldmann, Anja
    von Bonin, Malte
    Ewen, Eva-Maria
    Koristka, Stefanie
    Michalk, Irene
    Stamova, Slava
    Berndt, Nicole
    Gocht, Anne
    Bornhaeuser, Martin
    Ehninger, Gerhard
    Schmitz, Marc
    Bachmann, Michael
    ONCOIMMUNOLOGY, 2013, 2 (12):
  • [7] Combined 4-1BB and ICOS co-stimulation improves anti-tumor efficacy and persistence of dual anti-CD19/CD20 chimeric antigen receptor T cells
    Wang, Ying
    Zhong, Kailun
    Ke, Jun
    Chen, Xi
    Chen, Yi
    Shu, Wangyun
    Chen, Chunhuan
    Hu, Shan
    Sun, Xiaoke
    Huang, Haibin
    Luo, Chong
    Liu, Lifang
    Yang, Jiaming
    Zhang, Yongke
    Zhi, Huijun
    CYTOTHERAPY, 2021, 23 (08) : 715 - 723
  • [8] Aging affect the anti-tumor potential of dendritic cell vaccination, but it can be overcome by co-stimulation with anti-OXO40 or anti-4-1BB
    Sharma, S
    Dominguez, AL
    Lustgarten, J
    EXPERIMENTAL GERONTOLOGY, 2006, 41 (01) : 78 - 84
  • [9] cis-B7:CD28 interactions at invaginated synaptic membranes provide CD28 co-stimulation and promote CD8+T cell function and anti-tumor immunity
    Zhao, Yunlong
    Caron, Christine
    Chan, Ya-Yuan
    Lee, Calvin K.
    Xu, Xiaozhen
    Zhang, Jibin
    Masubuchi, Takeya
    Wu, Chuan
    Bui, Jack D.
    Hui, Enfu
    IMMUNITY, 2023, 56 (06) : 1187 - +
  • [10] Cis-B7:CD28 Interactions at Invaginated Synaptic Membranes Provide CD28 Co-stimulation and Promote CD8+ T Cell Function and Anti-tumor Immunity
    Ladowski, Joseph
    Luo, Xunrong
    TRANSPLANTATION, 2023, 107 (09) : 1860 - 1860